Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
IBBJohn Keeley 2014-12-31 Buy 0.01%$255.27 - $308.01
$ 380.0834%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neske, Tammy LynnSenior Officer 2015-07-27Buy2,000$6.156080.16view
Fitzgibbon, PierreDirector 2015-07-27Buy3,000$13.382740.66view
Neske, Tammy LynnSenior Officer 2015-07-27Buy5,000$6.076161.61view
Brown, EvanSenior Officer 2015-07-27Buy5,000$66234.67view
Riddell, Clayton H.10% Security Holder 2015-07-27Sell4,000$6.585676.29view
Meade, Harlan DonnleyDirector, Senior Officer 2015-07-27Buy8,000$0.04950100view
Stanyer, Warren WilliamDirector, Senior Officer 2015-07-27Buy1,000$0.15253286.67view
Stanyer, Warren WilliamDirector, Senior Officer 2015-07-27Buy4,000$0.15253286.67view
Dawson, Thomas C.Director 2015-07-27Buy1,800$4.887688.52view
Dawson, Thomas C.Director 2015-07-27Buy2,900$4.97656.73view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Targe Jul 23 2015 
    Shen Jun 24 2015 
    Shen Jun 24 2015 
    Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

    More From Other Websites
    Biogen’s 2Q15 Earnings Beat Wall Street Estimates Jul 28 2015
    Markets oversold, but these leaders still holding up Jul 28 2015
    Eli Lilly’s Solanezumab: A Possible Cure for Alzheimer’s? Jul 28 2015
    How to Get Bearish on Biotech With ETFs Jul 28 2015
    Next biotech deal brewing? Jul 27 2015
    More pain for stocks? Jul 27 2015
    Allergan to own 10% stake in Teva Jul 27 2015
    Biogen’s Alzheimer’s Drug BIIB037 Registers Some Success in Tests Jul 27 2015
    Biogen Presents Data from PRIME Study of Its Alzheimer’s Therapy Jul 27 2015
    Gilead Earnings Preview and The Moment of Truth Jul 27 2015
    What the Fed staff projects Jul 27 2015
    Bullish case for the market Jul 27 2015
    Investing With A High Probability Of Global Recession Jul 27 2015
    Goldman Sachs: Hedge Biotech Stocks Now Jul 27 2015
    Be aware of these surroundings friends Jul 27 2015
    Stock Market Video Analysis 7/24/15 Jul 24 2015
    Warning Flags: Dow Tumbles, S&P 500 Slides as Biotech Crumbles Jul 24 2015
    Pisani: What's worrying traders about Q3 earnings Jul 24 2015
    Focus on next week's earnings: Pisani Jul 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)